Volume 43, Issue 19, 14 May 2022

Issue @ A Glance

New therapeutic targets to reduce inflammation-associated cardiovascular risk: the CCL2–CCR2 axis, LOX-1, and IRF5

Filippo Crea

European Heart Journal, Volume 43, Issue 19, 14 May 2022, Pages 1777–1781, https://doi.org/10.1093/eurheartj/ehac233

• Extract
• View article

CardioPulse

Artificial intelligence in cardiovascular medicine in China

Yaling Han

European Heart Journal, Volume 43, Issue 19, 14 May 2022, Pages 1782–1783, https://doi.org/10.1093/eurheartj/ehac002

• Extract
• View article

Extreme cardiovascular risk—do we need a new risk category?

Krzysztof Dyrbuś and others

European Heart Journal, Volume 43, Issue 19, 14 May 2022, Pages 1784–1786, https://doi.org/10.1093/eurheartj/ehab771

• Extract
• View article

800 years of research at the University of Padua (1222–2022): contemporary insights into Sports Cardiology

Domenico Corrado and others

European Heart Journal, Volume 43, Issue 19, 14 May 2022, Pages 1787–1791, https://doi.org/10.1093/eurheartj/ehac043

• Extract
• View article

CardioPulse

Weekly Journal Scan

To repair or not to repair: the dilemma of tricuspid regurgitation associated with left-sided valvular heart disease

Leonarda Galiuto and Massimo Massetti

European Heart Journal, Volume 43, Issue 19, 14 May 2022, Pages 1792–1793, https://doi.org/10.1093/eurheartj/ehac132

• Extract
• View article

Special Article

Twitter promotion is associated with higher citation rates of cardiovascular articles: the ESC Journals Randomized Study

Ricardo Ladeiras-Lopes and others

European Heart Journal, Volume 43, Issue 19, 14 May 2022, Pages 1794–1798, https://doi.org/10.1093/eurheartj/ehac150

• Abstracts
• View article

State of the Art Review

Targeting the CCL2–CCR2 axis for atheroprotection

Marios K Georgakis and others

European Heart Journal, Volume 43, Issue 19, 14 May 2022, Pages 1799–1808, https://doi.org/10.1093/eurheartj/ehac094

• Abstracts
• View article
• Supplementary data

Clinical Research

Bone marrow activation in response to metabolic syndrome and early atherosclerosis

Ana Devesa and others

European Heart Journal, Volume 43, Issue 19, 14 May 2022, Pages 1809–1828, https://doi.org/10.1093/eurheartj/ehac102

• Abstracts
• View article
• Supplementary data

Editorial

Mischief in the marrow: a root of cardiovascular evil

Peter Libby and others

European Heart Journal, Volume 43, Issue 19, 14 May 2022, Pages 1829–1831, https://doi.org/10.1093/eurheartj/ehac149

• Abstract
• View article

Clinical Research

Vascular dysfunction and increased cardiovascular risk in hypospadias

Angela K Lucas-Herald and others

European Heart Journal, Volume 43, Issue 19, 14 May 2022, Pages 1832–1845, https://doi.org/10.1093/eurheartj/ehac112

• Abstracts
• View article
• Supplementary data

Editorial

Increased cardiovascular risk in boys born with hypospadias: intriguing observations and remaining questions

Nicolle Kränkel

European Heart Journal, Volume 43, Issue 19, 14 May 2022, Pages 1846–1848, https://doi.org/10.1093/eurheartj/ehac152

• Abstract
• View article

Clinical Research

Editor's Choice

Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes

Simon Kraler and others

European Heart Journal, Volume 43, Issue 19, 14 May 2022, Pages 1849–1860, https://doi.org/10.1093/eurheartj/ehac143

• Abstracts
• View article
• Supplementary data

Editorial

Soluble LOX-1 levels during acute coronary syndrome: a potent and multifaceted warning sign for cardiovascular risk

Andrei C Sposito

European Heart Journal, Volume 43, Issue 19, 14 May 2022, Pages 1861–1863, https://doi.org/10.1093/eurheartj/ehac173

• Abstract
• View article

Translational Research

Interferon regulatory factor-5-dependent CD11c⁺ macrophages contribute to the formation of rupture–prone atherosclerotic plaques

Andreas Edsfeldt and others

European Heart Journal, Volume 43, Issue 19, 14 May 2022, Pages 1864–1877, https://doi.org/10.1093/eurheartj/ehab920

• Abstracts
• View article
• Supplementary data

Editorial

Advancing therapeutic targeting of the vulnerable plaque

Alexandra A C Newman and others

European Heart Journal, Volume 43, Issue 19, 14 May 2022, Pages 1878–1880, https://doi.org/10.1093/eurheartj/ehac060

• Abstract
• View article

Discussion Forum

Is there an increased incidence of subclinical proximal deep vein thrombosis after mild to moderate course of SARS-CoV-2 infection?

Lars Müller and others

European Heart Journal, Volume 43, Issue 19, 14 May 2022, Page 1881, https://doi.org/10.1093/eurheartj/ehac162

• Extract
• View article

The everlasting challenge to identify deep vein thrombosis in both clinical practice and research

Christian-Alexander Behrendt and others

European Heart Journal, Volume 43, Issue 19, 14 May 2022, Pages 1882–1883, https://doi.org/10.1093/eurheartj/ehac164

• Extract
• View article

Cardiovascular Flashlight

Percutaneous closure of left ventricular pseudoaneurysm after direct surgical mitral valve implantation of balloon-expandable transcatheter prosthesis in severe mitral annular calcification

Luca Oechslin and others

European Heart Journal, Volume 43, Issue 19, 14 May 2022, Page 1884, https://doi.org/10.1093/eurheartj/ehac082

• Extract
• View article

Coronary artery fistula bypassed the left main coronary artery blocked by a large cardiogenic thrombus

Jiangyou Wang and others

European Heart Journal, Volume 43, Issue 19, 14 May 2022, Page 1885, https://doi.org/10.1093/eurheartj/ehac107

• Extract
• View article
• Supplementary data

Erratum

Erratum to: CETP inhibitors revisited

European Heart Journal, Volume 43, Issue 19, 14 May 2022, Page 1798, https://doi.org/10.1093/eurheartj/ehac022

• Extract
• View article

Erratum to: Leadless pacing: is this the end of the road for transvenous pacemakers?

European Heart Journal, Volume 43, Issue 19, 14 May 2022, Page 1848, https://doi.org/10.1093/eurheartj/ehac077

• Extract
• View article